New Delhi [India]: Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath
Hyderabad (Telangana) [India]: Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be “safe, well-tolerated, and immunogenic” in
New Delhi [India] : The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin
In a recent development, New Zealand has finally approved India-made vaccines, Covishield and Covaxin. The decision comes soon after Australia, New Zealand’s neighbour, recognised the
Hyderabad (Telangana) [India]: Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech’s Covaxin.As per phase-three clinical trials
New Delhi [India]: As many as 96 countries have recognised Covaxin and Covishield and both of these COVID-19 vaccines have received emergency use listing (EUL)
The UK will recognise India’s Covaxin jab as an approved Covid-19 vaccine for inbound travel from November 22, a move that is expected to benefit
New Delhi [India] ): Bharat Biotech’s US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use
Washington [US]: Travellers fully vaccinated against COVID-19 with Covaxin have been given the green light to enter the US from November 8. Talking to ANI
New Delhi [India]: Following the World Health Organization’s (WHO) Emergency Use Listing (EUL) for Bharat Biotech’s COVID-19 vaccine, Covaxin, Indian Council of Medical Research (ICMR)
Geneva [Switzerland]: The World Health Organisation (WHO) has said that Covaxin — COVID-19 vaccine developed by Bharata Biotech — is extremely suitable for low and
Geneva [Switzerland]: WHO Chief Scientist Soumya Swaminathan on Wednesday congratulated India after the World Health Organisation (WHO) granted approval for Emergency Use Listing (EUL) for
Georgetown [Guyana] : Guyana has recognised Bharat Biotech’s Covaxin COVID-19 vaccine, said High Commission of India in Georgetown, Guyana on Tuesday.“#Guyana has recognized #India’s indigenous
Glasgow [UK]: Prime Minister Narendra Modi on Monday thanked his Australian counterpart Scott Morrison after Canberra recognised Bharat Biotech’s Covaxin COVID-19 vaccine.“I thank my dear
Canberra [Australia] : Australian government on Monday gave recognition to Bharat Biotech’s Covaxin COVID-19 vaccine for the purpose of establishing a traveller’s vaccination status in
New Delhi [India] : The Supreme Court on Friday said that “it will wait for the response of the World Health Organisation (WHO) over Covaxin
The Government of the Sultanate of Oman on Wednesday added Indian-made Covaxin to the approved list of COVID-19 vaccines for travel to the country without
Muscat [Oman]: The Government of the Sultanate of Oman on Wednesday added Indian-made Covaxin to the approved list of COVID-19 vaccines for travel to the
New Delhi [India] : Union Health Minister Mansukh Mandaviya on Tuesday said that approval for Hyderabad-based Bharat Biotech’s COVID-19 vaccine Covaxin will be given on
Geneva [Switzerland]: Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO’s technical advisory group will meet on October 26 to
India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India’s Covishield and 6 crore doses
Subject Expert Committee gave recommendation to DCGI to use Covaxin for children, say official sources New Delhi [India], October 12 : Subject Expert Committee (SEC)
New Delhi [India]: German Ambassador to India, Walter J Lindner on Sunday asserted that his country would take the next step regarding Covaxin as soon
New Delhi [India] : The decision on Bharat Biotech’s Covid-19 vaccine, Covaxin Emergency Use Listing (EUL) by the World Health Organisation (WHO) is expected in
New Delhi [India]: India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin in the month of
The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech’s submission on emergency use listing (EUL) for its Covaxin COVID-19
Bharat Biotech has already completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age. New Delhi, India, September 28
The Delhi High Court on Monday sought the Centre’s stand on a petition filed by a cancer patient seeking direction to authorities concerned to allow
Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19
New Delhi [India]: The World Health Organisation’s (WHO) approval for Bharat Biotech’s COVID-19 vaccine, Covaxin, is expected this week, sources said on Monday.Bharat Biotech has
Hyderabad (Telangana) [India]: In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get
New Delhi [India]: The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the two
More than 136 crore COVID-19 vaccine doses are expected to be available till the end of this year, informed the Centre. New Delhi [India], August
Hyderabad (Telangana) [India]: Amid the reports of delayed production of its COVID-19 vaccine due to unsatisfactory test batch and quality issues, Hyderabad-based manufacturer Bharat Biotech
Hyderabad, Aug 5: Covaxin, India’s indigenous Covid-19 vaccine developed by Hyderabad-based Bharat Biotech, has received a certificate of Good Manufacturing Practice (GMP) compliance from the
New Delhi [India], August 5 : Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the
The monthly vaccine production capacity of Covishield is projected to be increased from 110 million doses per month to more than 120 million doses per
ICMR reveals that Covaxin is effective against the Delta Plus variant of COVID 19. New Delhi , india, August 2: A recent study by the
Ranchi, Jul 9: In a major respite for the state which is reeling with the shortage of vaccines in the battle against Coronavirus on Friday
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent
As the European Union relaxes travel restrictions under its ‘Green Passport’ scheme, India has requested the members of the 27-nation grouping to individually consider allowing
